Research Topics
| Clive RosendorffSummaryCountry: USA Publications
| Collaborators
|
Detail Information
Publications
Correlation of arterial blood pressure and compliance with left ventricular structure and function in the very elderlyClive Rosendorff
Department of Medicine, James J Peters VA Medical Center, Bronx, NY 10468, USA
J Am Soc Hypertens 6:48-55. 2012..Arterial blood pressure is correlated with LV structure and function in the very elderly, but arterial stiffness, as measured by diastolic pulse contour analysis, is not...
Evidence for a lower target blood pressure for people with heart diseaseClive Rosendorff
Mount Sinai School of Medicine, New York, New York, USA
Curr Opin Cardiol 24:318-24. 2009..The review assesses the evidence for the benefit of lower blood pressure (BP) targets in hypertension management...
Cardiovascular risk factors for Alzheimer's diseaseClive Rosendorff
Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA
Am J Geriatr Cardiol 16:143-9. 2007..If this is the case, the identification of modifiable risk factors for dementia becomes a research priority and early intervention aimed at reducing those cardiovascular risk factors a therapeutic imperative...
C-reactive protein and familial risk for dementia: a phenotype for successful cognitive agingJeremy M Silverman
Department of Psychiatry, Mount Sinai School of Medicine, New York, USA
Neurology 79:1116-23. 2012....
Hypertension and atrial fibrillationOrson Go
Mount Sinai School of Medicine, Medicine 111, James J Peters VA Medical Center, 130 West Kingsbridge Road, Bronx, NY 10468, USA
Curr Cardiol Rep 11:430-5. 2009..Several large prospective trials with longer follow-up periods are in progress. These trials may provide definitive evidence for the use of these agents in the prevention of AF...
Homocysteine and cognitive function in very elderly nondemented subjectsRebecca K West
Mount Sinai School of Medicine, New York, NY
Am J Geriatr Psychiatry 19:673-7. 2011..To examine the association of homocysteine with cognitive functioning in very elderly community-dwelling individuals (80 years or older)...
Comparison of olmesartan medoxomil versus amlodipine besylate on regression of ventricular and vascular hypertrophyClive Rosendorff
Department of Medicine, Mount Sinai School of Medicine and the James J Peters VA Medical Center, Bronx, New York, USA
Am J Cardiol 104:359-65. 2009....
Do statins lower blood pressure?Simardeep Mangat
Department of Medicine, Mount Sinai School of Medicine, New York, and the James J Peters VA Medical Center, Bronx, New York 10468, USA
J Cardiovasc Pharmacol Ther 12:112-23. 2007..Despite predictions made on the basis of the vasoprotective actions of statins, the blood-pressure-lowering effects of statins are at best modest...
Better memory functioning associated with higher total and low-density lipoprotein cholesterol levels in very elderly subjects without the apolipoprotein e4 alleleRebecca West
Mount Sinai School of Medicine, New York, NY, USA
Am J Geriatr Psychiatry 16:781-5. 2008..To examine the association of cholesterol with cognitive functioning in oldest old community dwelling individuals with and without the apolipoprotein e4 (APOE4) allele...
Evidence for aggressive blood pressure-lowering goals in patients with coronary artery diseaseMonisankar Roy
Mount Sinai School of Medicine, James J Peters VA Medical Center, Bronx, NY 10468, USA
Curr Atheroscler Rep 12:134-9. 2010..This review evaluates the evidence for the benefit of lower BP targets in hypertension management...
Association between transforming growth factor-beta(1) and left ventricular mass and diameter in hypertensive patientsJesus L Almendral
James J Peters Department of Veterans Affairs Medical Center, Bronx, NY, and Mount Sinai School of Medicine, New York, NY, USA
J Am Soc Hypertens 4:135-41. 2010..These findings indicate that serum TGF-beta(1) levels are related to left ventricular structure in hypertensive subjects, suggesting its possible involvement in the process of hypertensive left ventricular remodeling...
Hypertension and coronary artery disease: a summary of the American Heart Association scientific statementClive Rosendorff
Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA
J Clin Hypertens (Greenwich) 9:790-5. 2007..In patients with more severe heart failure, an aldosterone antagonist and hydralazine/isosorbide dinitrate (in black patients) should be considered...
Calcium antagonists in the treatment of hypertension in patients with ischaemic heart diseaseClive Rosendorff
The Mount Sinai School of Medicine and the Veterans Affairs Medical Center, 130 West Kingsbridge Road, Bronx, NY 10468, USA
Expert Opin Pharmacother 4:1535-41. 2003..If beta-blockers are contraindicated and if there is no LV dysfunction, a non-dihydropyridine calcium antagonist can be substituted...
Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer diseaseJun Wang
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA
J Clin Invest 117:3393-402. 2007..These preclinical studies suggest that certain antihypertensive drugs may have AD-modifying activity and may protect against progressive Abeta-related memory deficits in subjects with AD or in those at high risk of developing AD...
Managing the hypertensive patient with ischemic heart diseaseClive Rosendorff
Department of Medicine, Mount Sinai School of Medicine and the Bronx VAMC, NY 10468, USA
Curr Hypertens Rep 4:350-7. 2002..A thiazide diuretic and/or a dihydropyridine calcium channel blocker could be added for blood pressure control. Calcium channel blockers should be avoided if there is significant left ventricular dysfunction...
More light pleaseClive Rosendorff
Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA
J Clin Hypertens (Greenwich) 9:285-6. 2007
The J-point revisitedClive Rosendorff
Hypertension 51:e34; author reply e35-6. 2008
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: is there a difference in response and any advantage to using them together in the treatment of hypertension?Marvin Moser
J Clin Hypertens (Greenwich) 10:489-96. 2008..by Marvin Moser, MD, Clinical Professor of Medicine at Yale University School of Medicine, and included Clive Rosendorff, MD, PhD, Professor of Medicine at Mount Sinai School of Medicine and William B...
Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Mahboob Rahman
Case Western Reserve University, University Hospitals of Cleveland Case Medical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, USA
Am J Kidney Dis 52:412-24. 2008..Dyslipidemia is common in patients with chronic kidney disease. The role of statin therapy in the progression of kidney disease is unclear...
New insights into hypertension management in acute stroke: let the CHHIPS fall where they mayClive Rosendorff
J Clin Hypertens (Greenwich) 10:425-6. 2008
Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and PreventiClive Rosendorff
Veterans Health Administration, USA
Circulation 115:2761-88. 2007
Normal homocysteine levels in well-functioning oldest-old individuals despite low kidney functionMichal Schnaider Beeri
J Am Geriatr Soc 54:1623-5. 2006
